At the end of the 19th century William Osler noted key differences in the presentation of pneumonia in the elderly. His observational perspicuity has withstood the passage of time. The following article pays deference to this Canadian physician, summarizing not only differences in clinical presentation but also including an update on epidemiology, aetiology and management.
Community Acquired Pneumonia in Adults Guideline Group.BTS guidelines for the management of community acquired pneumonia in adults: update 2009. October 2009, Vol 64, SupplementIII.
2.
Jokinen C., Heiskanen L., Juvonen H., et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol1993; 137: 977-988.
3.
Mortensen EM , Kapoor WN, Chang CC, et al. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis2003; 37: 1617-1624.
4.
Venkatesan P. , Gladman J., Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax1990; 45: 254-258.
5.
Fernandez-Sabe N., Carratala J., Roson B., et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes . Medicine2003; 82: 159-169.
6.
Cassel C., Lepzig R., Cohen H., Larson B., and Meier D.Geriatric medicine: an evidence based approach. 4th ed. New York: Springer, 2003, p.152.
7.
Mittl RL Jr , Schwab RJ, Duchin JS, et al. Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med1994;149(3Pt1): 630-635.
8.
Martin CM, Kunin CM, Gottlieb LS, and Finland M.Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. Arch Intern Med1959 ; 103: 532-542.
9.
Goossens H., Ferech M., Vander Stichele R., Elseviers M.; ESAC Project Group.Outpatient antibiotic use in Europe and association with resistance: a cross-national database study . Lancet2005; 365: 579-587.
10.
Taylor EL, Marrie TJ, Fine MJ, et al. Observations from a multicentre study on the use of the sputum specimen in patients hospitalized with community-acquired pneumonia. Can J Infect Dis1999; 10: 39-46.
11.
Lim WS, van der Eerden MM, Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax2003; 58: 377-382.
12.
Marrie TJ, Haldane EV, Faulkner RS, et al. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?J Am Geriatr Soc1985; 33: 671-680.
13.
Peter MA, Calverley PM, Anderson JA, Celli B., et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med2007;356:775-89.
14.
Jefferson T. , Rivetti D., Rivetti A. et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Jefferson et al. Lancet2005; 366: 1165-74.
15.
Jefferson T. , Di Pietrantonj C., Al-Ansary LA et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev.2010 ;2:CD004876.
16.
Ruiz M., Ewig S., Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med1999 ;160:397-405.
17.
Lim WS, Macfarlane JTA prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J2001;18:362-8.
18.
Marrie TJ, Blanchard W.A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc1997;45:50-5.
19.
Kikuchi R., Watabe N., Konno T., et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med1994;150:251-3.
